Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prashanth Prithviraj

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Frontiers in Medicine|July 1, 2022
Precision Medicine: An Optimal Approach to Patient Care in Renal Cell CarcinomaRevati Sharma, George Kannourakis, Prashanth Prithviraj, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast CancerArpita Poddar, Sushma R Rao, Prashanth Prithviraj, et al.
Frontiers in Oncology|March 13, 2015
Embryonic Chicken Transplantation is a Promising Model for Studying the Invasive Behavior of Melanoma CellsAparna Jayachandran, Sonja J McKeown, Briannyn L Woods, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 8, 2021
Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinomaRevati Sharma, Elif Kadife, Mark Myers, et al.
Journal of Clinical Medicine|April 30, 2021
Combined Inhibition of TGF-β1-Induced EMT and PD-L1 Silencing Re-Sensitizes Hepatocellular Carcinoma to Sorafenib TreatmentRitu Shrestha, Prashanth Prithviraj, Kim R Bridle, et al.
Cancers|May 13, 2023
In Vitro and In Silico Analysis of Epithelial-Mesenchymal Transition and Cancer Stemness as Prognostic Markers of Clear Cell Renal Cell CarcinomaRevati Sharma, Showan Balta, Ali Raza, et al.
International Journal of Molecular Sciences|February 15, 2022
CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder CancerLu Cao, Kim R Bridle, Ritu Shrestha, et al.
Journal of Biomedical Science|February 23, 2024
The role of pregnancy associated plasma protein-A in triple negative breast cancer: a promising target for achieving clinical benefitsArpita Poddar, Farah Ahmady, Sushma R Rao, et al.
Oncotarget|May 6, 2015
Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasionPrashanth Prithviraj, Matthew Anaka, Sonja J McKeown, et al.
Journal for Immunotherapy of Cancer|November 21, 2020
Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanomaVictoria Atkinson, Adnan Khattak, Andrew Haydon, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Frontiers in Medicine|July 1, 2022
Precision Medicine: An Optimal Approach to Patient Care in Renal Cell CarcinomaRevati Sharma, George Kannourakis, Prashanth Prithviraj, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast CancerArpita Poddar, Sushma R Rao, Prashanth Prithviraj, et al.
Frontiers in Oncology|March 13, 2015
Embryonic Chicken Transplantation is a Promising Model for Studying the Invasive Behavior of Melanoma CellsAparna Jayachandran, Sonja J McKeown, Briannyn L Woods, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 8, 2021
Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinomaRevati Sharma, Elif Kadife, Mark Myers, et al.
Journal of Clinical Medicine|April 30, 2021
Combined Inhibition of TGF-β1-Induced EMT and PD-L1 Silencing Re-Sensitizes Hepatocellular Carcinoma to Sorafenib TreatmentRitu Shrestha, Prashanth Prithviraj, Kim R Bridle, et al.
Cancers|May 13, 2023
In Vitro and In Silico Analysis of Epithelial-Mesenchymal Transition and Cancer Stemness as Prognostic Markers of Clear Cell Renal Cell CarcinomaRevati Sharma, Showan Balta, Ali Raza, et al.
International Journal of Molecular Sciences|February 15, 2022
CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder CancerLu Cao, Kim R Bridle, Ritu Shrestha, et al.
Journal of Biomedical Science|February 23, 2024
The role of pregnancy associated plasma protein-A in triple negative breast cancer: a promising target for achieving clinical benefitsArpita Poddar, Farah Ahmady, Sushma R Rao, et al.
Oncotarget|May 6, 2015
Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasionPrashanth Prithviraj, Matthew Anaka, Sonja J McKeown, et al.
Journal for Immunotherapy of Cancer|November 21, 2020
Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanomaVictoria Atkinson, Adnan Khattak, Andrew Haydon, et al.
Pageof 2